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derived from human induced pluripotent sta b s t r a c t
Human induced pluripotent stem cells (hiPSCs) are considered as a powerful tool for drug and chemical
screening and development of new in vitro testing strategies in the ﬁeld of toxicology, including
neurotoxicity evaluation. These cells are able to expand and efﬁciently differentiate into different types of
neuronal and glial cells as well as peripheral neurons. These human cells-based neuronal models serve as
test systems for mechanistic studies on different pathways involved in neurotoxicity.
One of the well-known mechanisms that are activated by chemically-induced oxidative stress is the
Nrf2 signaling pathway. Therefore, in the current study, we evaluated whether Nrf2 signaling machinery
is expressed in human induced pluripotent stem cells (hiPSCs)-derived mixed neuronal/glial culture and
if so whether it becomes activated by rotenone-induced oxidative stress mediated by complex I inhi-
bition of mitochondrial respiration.
Rotenone was found to induce the activation of Nrf2 signaling particularly at the highest tested
concentration (100 nM), as shown by Nrf2 nuclear translocation and the up-regulation of the Nrf2-
downstream antioxidant enzymes, NQO1 and SRXN1. Interestingly, exposure to rotenone also
increased the number of astroglial cells in which Nrf2 activation may play an important role in neuro-
protection. Moreover, rotenone caused cell death of dopaminergic neurons since a decreased percentage
of tyrosine hydroxylase (THþ) cells was observed. The obtained results suggest that hiPSC-derived mixed
neuronal/glial culture could be a valuable in vitro human model for the establishment of neuronal
speciﬁc assays in order to link Nrf2 pathway activation (biomarker of oxidative stress) with additional
neuronal speciﬁc readouts that could be applied to in vitro neurotoxicity evaluation.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
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Human induced pluripotent stem cells (hiPSCs) represent
unique tools for toxicity screening and improved mechanistic un-
derstanding of chemically-induced adverse effects (Hou et al.,
2013; Kumar et al., 2012; Yap et al., 2015). This is in line with the
report “Toxicity Testing in the twenty-ﬁrst Century” released in
2007 by the National Research Council of the United States that
encourages the use of human cell-based models for in vitro toxicity
testing (NRC, 2007). Opposite to human cell lines derived from
carcinoma tissues (e.g. neuroblastoma cell lines), which do not
possess normal cell physiology, hiPSCs have been identiﬁed as a
potential source of various cell types for toxicity testing (Hou et al.,
2013). HiPSCs share similar characteristics with human embryonic
stem cells (hESCs) (Krueger et al., 2010; Pistollato et al., 2012), i.e.
are characterized by unlimited self-renewal and capacity tonder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2016; Robinton and Daley, 2012), including neurons and glial cells.
Moreover, these stem cell-based systems offer an innovative
alternative for obtaining a large number of human cells, serving as a
valuable tool for the development of in vitro models for toxicity
testing (Avior et al., 2016), often applicable for high throughput
screening (HTS) (Desbordes and Studer, 2013). Therefore, hiPSC-
derived in vitro models have a great potential to improve the efﬁ-
cacy of drug discovery as well as human risk assessment. However,
before this can be achieved, quality control criteria, speciﬁc for the
morphological and functional characterization of hiPSC-derivatives
are required to ensure reproducibility and reliability of data pro-
duced for regulatory toxicology use (Pistollato et al., 2012). For
instance, the expression of Paired Box 6 (Pax6) and Nestin will be
important to characterize neuroectodermal commitment, analysis
of MAP2, synaptophysin (SYN) and microtubule-associated protein
tau (MAPT) to conﬁrm neuronal differentiation, while expression of
GFAP is essential to determine the presence of astrocytes.
Oxidative stress is one of the non-cell speciﬁc cellular responses
(including neurons and astrocytes) determined at early stages of
toxicity and induced by many different classes of chemicals. Key
regulators of the Antioxidant-Response-Element-(ARE)-driven
cellular defense mechanisms against oxidative stress is the Nu-
clear factor (erythroid-derived 2)-like 2 (Nrf2), which has a cyto-
protective role in several diseases (Ramsey et al., 2007). Upon
activation, Nrf2 binds to the promoter regions of several genes,
inducing the expression of enzymes that support detoxiﬁcation
processes that take place in many neurodegenerative diseases
(Ramsey et al., 2007). Moreover, Nrf2 plays a central role in the
regulation of anti-oxidant defense mechanisms in many cell types
(if not all). Therefore, analysis of Nrf2 signaling activation could
serve as a base for the establishment of a horizontal assay, relevant
to different organ toxicity, permitting assessment of oxidative
stress induction. Accordingly, several studies have shown that Nrf2
up-regulation is a biomarker of an increased production of reactive
oxygen species (ROS) that contribute to various neurodegenerative
diseases, including Parkinson disease (Ramsey et al., 2007; Tufekci
et al., 2011).
In the current study, we exposed hiPSC-derived mixed neuronal
and glial cultures to rotenone, an inhibitor of mitochondrial res-
piratory complex I that is linked to Parkinson disease, as shown in
animal models upon chronic exposure to rotenone at low doses
(Cannon et al., 2009; Sherer et al., 2003; Tanner et al., 2011). In
particular, in a rodent model of Parkinson disease rotenone was
found to induce irreversible, selective dopaminergic neuronal cell
death and formation of Lewy body-like cytoplasmic inclusions
(Cannon et al., 2009; Sherer et al., 2003; Tanner et al., 2011).
In this study we assessed the activation of Keap1-Nrf2-ARE
pathway in a hiPSC-derived neuronal culture upon acute (24 h)
treatment with non-cytotoxic concentrations of rotenone (i.e.,
1e10e100 nM), and detected its possible effects on neuronal and
glial cell markers. The evaluation of the expression of the Nrf2
pathway in human stem cell-derived neuronal/glial models could
serve for future in vitro screening and prioritization for further
testing of potential neurotoxic compounds that act through Nrf2
signaling activation and induction of oxidative stress.
2. Materials and methods
2.1. Human iPSC culture, expansion and treatments
IMR90-hiPSCs were kindly provided by Dr. Marc Peschanski (I-
stem, France). IMR90 ﬁbroblast cell line was established on 07/07/
1975 using explants of minced lung tissue obtained from a clinically
normal 16 week old fetus and they exhibit a normal femalePlease cite this article in press as: Zagoura, D., et al., Evaluation of the ro
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Detail.aspx?Ref¼I90-52&PgId¼166).
IMR90 ﬁbroblasts were reprogrammed into hiPSCs at I-Stem by
viral transduction of 2 transcription factors (Oct4 and Sox2) by
using the pMIG vectors (Addgene).
hiPSCs were cultured, under feeder-free conditions, on matri-
gel™ hESC-qualiﬁed matrix (Corning) pre-coated Petri-dishes in
the presence of mTeSR™1 medium containing mTeSR™1 5X sup-
plements (Stem Cell Technologies) prepared following manufac-
turer's instructions. HiPSC colonies were passaged by micro-
dissection using a 30G needle. Cells were treated with 1, 10,
100 nM rotenone (Sigma-Aldrich, dissolved in DMSO) for 24 h,
accounting for solvent control analysis. A 24 h treatment with
10 mM and 100 mM hydrogen peroxide (H2O2, Sigma-Aldrich) was
used as a positive control for induction of oxidative stress and
activation of the Nrf2 pathway.
Additionally, human neurons derived from adult brain tissue
(InnoProt, reference number P10151), and rat embryonic cortical
neurons (Sigma-Aldrich, embryonic day 18, reference number
R882N), cultured as described by the manufacturers, were used as
benchmarks of neuronal cell model performance.
2.2. iPSC-derived neural stem cell expansion and neuronal
differentiation protocols
IMR90 cells were differentiated toward neurons and glia
following a protocol described in https://ecvam-dbalm.jrc.ec.
europa.eu/beta/index.cfm/methodsAndProtocols/index, which is a
modiﬁed version of the method described by Pistollato (Pistollato
et al., 2014). Brieﬂy, IMR90-derived colonies cultured on matri-
gel™ hESC-qualiﬁedmatrix (Corning) coated dishes were manually
microdissected into 200 mm  200 mm fragments using a 30G
needle. For the generation of embryoid bodies (EBs), fragments
were transferred into a low attachment Petri-dish (Greiner) and
cultures in EB medium (Supplementary Table 1). After 48 h,
generated EBs were plated on laminin (Sigma-Aldrich)-coated
dishes and cultured in neuroepithelial induction (NRI) medium
(Supplementary Table 2) for further 7 days. On day 8, neuro-
epithelial aggregates (rosettes) were visible and were cut in frag-
ments using a 30G needle under a phase contrastmicroscope. Then,
rosettes were spun down, resuspended in 1 ml of phosphate-
buffered saline (PBS, 1X) and partially dissociated using a p1000
tip. Finally, dissociated rosettes were plated on laminin-coated
dishes and cultured in the presence of neural differentiation (ND)
medium for 3 weeks (Supplementary Table 3).
Moreover, a protocol for the expansion of rosette-derived neural
stem cells (NSCs) was developed, as described in https://ecvam-
dbalm.jrc.ec.europa.eu/beta/index.cfm/methodsAndProtocols/
index. Brieﬂy, rosette-derived NSCs were passaged by enzymatic
dissociation using 0.05% Trypsin-EDTA (ThermoFisher, 15400-054),
and replated on matrigel® basement membrane matrix (Corning)
coated dishes in the presence of neural induction (NI) medium
(Supplementary Table 4) (50,000 cells/cm2). NI medium was
refreshed every other day. At early passages (1e4), a cell plating
density of about 75,000 cells/cm2 was applied to improve cell
viability after passaging. NSCs were cryopreserved in a freezing
solution formulated as follows: 50 mg/ml BSA diluted in complete
mTeSR-1 Basal Medium (with mTeSR-1 supplements) (50%), com-
plete NI medium (40%) and DMSO (10%). NSCs were differentiated
into neuronal mixed cultures using NDmedium as described above.
2.3. Immunocytochemistry
About 6000e7000 cells/well in 96 well plates were plated and
differentiated for 21 days. On day 21, cells were treated with eithertenone-induced activation of the Nrf2 pathway in a neuronal model
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with cold 4% paraformaldehyde, washed in PBS 1X, permeabilized
in PBS 1X containing 0.1% Triton-X-100 and 3% bovine serum al-
bumin (BSA) for 15min at room temperature, and further incubated
with 3% BSA/1X PBS (blocking solution) to prevent nonspeciﬁc
binding of the antibodies. The cells were then incubated with pri-
mary antibodies as follows: neuroﬁlament 200 (NF200, rabbit,
1:1000, Sigma-Aldrich), glial ﬁbrillary acidic protein (GFAP, mouse,
1:500, Merck-Millipore), microtubule-associated protein-2 (MAP2,
mouse, 1:500, Sigma-Aldrich), synaptophysin (SYN, rabbit, 1:200,
Abcam), Nrf2 (rabbit), Keap1 (rabbit), sulﬁredoxin1 (SRXN1, goat),
NAD(P)H quinone oxidoreductase 1 (NQO1, goat) (all 1:200,
Abcam), nestin (rabbit, 1:200, Sigma-Aldrich), tyrosine hydroxylase
(TH, rabbit, 1:200, Millipore), gamma-aminobutyric acid (GABA,
mouse, 1:100, Sigma-Aldrich), vesicular glutamate transporter 1
(VGlut1, rabbit, 1:500, Abcam) in blocking solution overnight at
4 C. The cells were washed with PBS and further incubated with
ﬂuorochrome-conjugated secondary antibodies (1:1000, Invi-
trogen). Nuclei were counterstained with DAPI dye (0.3 mM, Sigma-
Aldrich). Quantiﬁcation of mean ﬂuorescence intensity and of the
relative percentages of cell types was performed using two speciﬁc
ArrayScan algorithms: Cytotoxicity V.4 and NucTrans V.4 bio-
applications. Both the applications apply a speciﬁc nuclear mask
around the DAPI staining deﬁned according to nuclear morphology,
discarding invalid nuclei (i.e., nuclei that were pyknotic, bright and/
or dense clumps of cells) and, on the valid nuclei (i.e., homogenous
round-shaped nuclei, indicative of live cells) an additional cell body
shape mask was applied according to the type of antibody/antigen
staining, as already described (O'Brien et al., 2006). The NucTrans
V.4 algorithm calculates the level of ﬂuorescence intensity both in
the nucleus and the cytoplasm, applying respectively a circular
mask (for nuclear signal) and a ring shape mask (for cytoplasmic
signal). Secondary antibody incubation alone was used to deter-
mine the intensity level of ﬂuorescent background that was sub-
tracted. The ArrayScan™ XTI High Content Platform was set up to
take aminimumof 20 pictures/well. Each stainingwas done on 7e8
internal replicates for each condition.
2.4. Electrophysiological measurements
Dissociated rosette-like structures (differentiation day 7) or
NSCs derived from rosettes were plated on Multielectrode arrays
(MEAs) (1  105 cells/MEA chip) containing complete ND medium
and differentiated for 3 weeks as described above. Additionally,
human neurons derived from adult brain tissue (InnoProt,
Ref. number P10151), and rat embryonic cortical neurons (Sigma-
Aldrich, embryonic day 18, Ref. number R882N) were cultured
respectively for 2 and 3 weeks directly on MEA chips to allow
neuronal network formation and maturation. Electrical activity of
these cultures was evaluated in comparison to the hiPSC-derived
neuronal model. At the end of differentiation, the mixed hiPSC-
derived neuronal cultures were exposed to 1-10-100 nM rote-
none for 24 h, on MEA plates which were sealed with a semi-
permeable membrane (standard MEAs) in a laminar ﬂow hood to
keep the cultures sterile for repeated measurements. Each chip
(single well) contains 60 microelectrodes, aligned in an 8  8
square grid, with the four corners missing. One of the electrodes
can be replaced by one ground reference, allowing recording from
the remaining 59 electrodes. The mean ﬁring rate (MFR, number of
spikes/min) was recorded prior to the addition of rotenone (which
represents the control value) and, after 24 h, MEA recording was
repeated and data were normalized to control (Ctr). All data
represent the average of at least n ¼ 3 biological replicates. The
measurements were performed with a MEA1060-Inv-BC-ampliﬁer
with integrated temperature process control adjusted to 37 C andPlease cite this article in press as: Zagoura, D., et al., Evaluation of the ro
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channel systems). Peaks from MEA raw data were detected using
threshold limit of4.7s, wheres represents the standard deviation
of the basal noise. From each MEA, the number of spikes/min and
bursts/30 min were calculated (a burst was considered as a train of
at least 2e5 action potentials occurring max every 100 millisec).
Spike number data were normalized with respect to baseline ac-
tivity for each MEA separately. Post-recording data were processed
with NeuroExplorer (NexTechnologies) and Excel (Microsoft).
2.5. Quantitative real-time PCR (qPCR) analyses
Analysis of gene expression by qPCR was performed on
differentiated and rotenone-treated (i.e., 1e10-e100 nM) and
untreated (control) cells. RNA was isolated using the RNAqu-
eous®-Micro Kit (ThermoFisher) according to manufacturer's in-
structions, and 500 ng of total RNA was reverse transcribed using
the High Capacity cDNA Reverse Transcription Kit (as directed,
ThermoFisher). qPCR reactions were run in duplicate using Taq-
Man® Gene Expression Master Mix (ThermoFisher) and the
following TaqMan gene expression assays (all from Thermo-
Fisher): GFAP (Hs00909233_m1), MAP2 (Hs00258900_m1),
NQO1 (Hs02512143_s1), SRXN1 (Hs00607800_m1), HMOX1 (Hs0
1110250_m1), GSR (Hs00167317_m1), PAX6 (Hs01088112_m1),
NES (Hs00707120_s1), GRIA1 (Hs00181348_m1), GAP43 (Hs
00967138_m1), GABRA3 (Hs00968132_m1), GABRA1 (Hs0
0168058_m1), NR4A2 (Hs00428691_m1), TH (Hs00165941_m1),
GAPDH (Hs02758991_g1), ACTB (Hs99999903_m1). Fluorescent
emission was recorded in real-time using the ABI PRISM
Sequence Detection System 7900HT (Applied Biosystems). PCR
ampliﬁcation conditions consisted of 45 cycles with primers
annealing at 60 C. Relative RNA quantities were normalized to
the reference genes GAPDH and ACTB and untreated cells were
used as a calibrating condition (DDCt Method).
2.6. Statistical analysis
Statistical signiﬁcance was assessed by one-way ANOVA with
Dunnett's Multiple Comparison Test as Post Test, comparing all
columns vs control (Ctr) column using the GraphPad Prism 5
software (http://www.graphpad.com/). All data represent the
average of at least n ¼ 3 biological replicates ±standard error mean
(S.E.M.) For all graphs, an asterisk over a bar indicates a signiﬁcant
difference with the control group, an asterisk over a bracket shows
a signiﬁcant difference as indicated. For all graphs, *p < 0.05,
**p < 0.01, ***p < 0.001.
3. Results
3.1. Differentiation of hiPSCs into mixed neuronal/glial cultures
IMR90-hiPSCs were directly differentiated into mixed cultures
of neuronal and glial cells for 28 days (Fig. 1A, part 1). In parallel, a
protocol for rosette-derived neural stem cell (NSC) expansion and
cryopreservation was developed as summarized in Fig. 1A (part 2).
NSCs could be further differentiated into neurons and glial cells for
21 days (Fig. 1A, part 2).
Differentiated neuronal-like cells (28 days of differentiation)
derived from IMR90-hiPSCs expressed high level of the major
neuronal cytoskeleton protein, neuroﬁlament 200 (NF200,
approximately 65% of cells) and about 25e30% of the cells were
positive for the glial ﬁbrillary acidic protein (GFAP), marker of
astroglia (Fig. 1B, C). We have also detected positive cells for the late
marker of dendrites, microtubule-associated protein 2 (MAP2), as
well as the pre-synaptic vesicle protein synaptophysin (Fig. 1B,tenone-induced activation of the Nrf2 pathway in a neuronal model
ernational (2016), http://dx.doi.org/10.1016/j.neuint.2016.09.004
Fig. 1. Neuronal differentiation starting from IMR90-hiPSCs or from rosette-derived neural stem cells (NSCs) into mixed neuronal and glial cultures. (A) Schematic rep-
resentation of the neural differentiation protocol: IMR90-hiPSC colonies were cut into fragments to form embryoid bodies (EBs), EBs were further cultured in the presence of
neuroepithelial induction (NRI) medium to generate neuroectodermal derivatives (or rosettes), which were further differentiated into mature neuronal and glial cells in neuronal
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population obtained by expanding rosette-derived NSCs and their
further differentiation into neurons (Fig. 1B, bottom panels).
Moreover, in line with our previous report (Pistollato et al., 2014),
we found that ~ 25e30% of cells still retained the expression of
nestin after differentiation (Fig. 1B, C), and we observed no
remarkable differences in the proportions of MAP2þ, nestinþ and
GFAP þ cells between the two cell models (i.e., IMR90-hiPSC- vs
IMR90-NSC-derivatives) (Fig. 1C).
Analysis of speciﬁc neuronal subpopulations in the two cultures
models revealed that GABAergic neurons represented ~15e20%,
dopaminergic neurons ~13e20%, and glutamatergic neurons
~35e42% of total cell number, as shown by analyses of immuno-
cytochemistry for gamma-aminobutyric acid (GABA), tyrosine hy-
droxylase (TH) and Vesicular Glutamate Transporter 1 (VGlut1)
respectively (Fig. 1C). The percentages of these cell subpopulations
did not remarkably differ comparing differentiated cultures derived
from IMR90-hiPSCs (Fig. 1A, part A) vs differentiated cells derived
from IMR90-NSCs (Fig. 1A, part B).
Moreover, we assessed the spontaneous electrical activity of
IMR90-derived neuronal-like cells. Rosette-derived NSCs (7 DIV)
were plated on Multi Electrode Array (MEA) single-well chips
(Multi Channel Systems) and further differentiated for 21 days
(Fig. 1A). On day 28 of differentiation, neuronal spontaneous elec-
trical activity was recorded, with a mean ﬁring rate (MFR) of ~293
spikes/minute (Fig. 1E). Analogously, neurons derived from
expanded NSCs yielded similar results with MFR of ~239 spikes/
minute (Fig. 1D, E and Supplementary Fig. 1A, B). Additionally, we
compared the MFR values of the hiPSC neuronal cultures with two
different neuronal cell models: human neurons derived from adult
brain tissue (Supplementary Fig. 1C) and rat embryonic cortical
neurons, respectively cultured for 2 and 3 weeks on MEA chips to
allow neuronal network maturation. Primary culture of rat neurons
showed signiﬁcantly higher electrical activity, with a MFR of ~730
spikes/min (Fig. 1E), presenting a massive generation of bursts as
previously described (Vassallo et al., 2016). The MFR recorded from
adult human neuronal cultures resulted in similar MFR value (~300
spikes/min) (Fig. 1E and Supplementary Fig. 1D) to the ones
recorded for hiPSC-derived neurons. However, while human adult
neurons generated also some bursts (Supplementary Fig. 1E), we
could not observe bursts in hiPSC-neuronal cultures (data not
shown).
3.2. Nuclear translocation of Nrf2 and upregulation of the
antioxidant enzymes NQO1 and SRXN1 after exposure to different
concentrations of rotenone
Rotenone has been shown to cause oxidative stress triggering
the translocation of Nrf2 from the cytoplasm into the nucleus,
followed by induction of the Nrf2-ARE target gene transcription
(Tufekci et al. 2011). In order to assess the effects of rotenone,
IMR90-derived neurons were exposed to 3 different concentrations
of rotenone (1, 10 and 100 nM) for 24 h (Fig. 2A). These concen-
trations were established according to previous studies (Kovac
et al., 2015; Lee et al., 2003). 1 nM concentration seems to be
relevant to human exposure, as 0.55 ng/ml (~1 nM) was previouslydifferentiation (ND) medium (1). Rosette-derived neural stem cells (NSCs) could be expan
presence of ND medium to form mixed neuronal/glial cultures (2). (B) Representative immun
(NF200: red), glial ﬁbrillary acidic protein (GFAP: green), microtubule-associated protein-2
neurons stained for NF200 (green), GFAP (red), MAP2 (red) and nestin (green) (bottom pan
sicular glutamate transporter 1 (VGlut1) and tyrosine hydroxylase (TH) positive cells by HCI,
obtained from expanded and cryopreserved IMR90-hiPSC derived NSCs. (D) Representative r
was carried out for a minimum of 600 s, vertical bars represent single spikes. (E) Mean ﬁrin
derived neurons, human adult neurons, and rat embryonic cortical neurons.
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Analysis of total live cell numbers, by means of DAPI nuclear
staining and high content imaging (HCI) (Fig. 2B) showed that
rotenone at 1 and 10 nM was non-cytotoxic, however, 100 nM
concentration caused a low level of cytotoxicity in IMR90-neurons
(~15% cell death, not statistically signiﬁcant). Additionally, we could
not detect any signiﬁcant change in the MFR value upon exposure
to the three studied concentrations of rotenone (Fig. 2C and
Supplementary Fig. 2), suggesting that rotenone at these concen-
trations and time of exposure (24 h) did not compromise sponta-
neous neuronal electrical activity.
Immunoﬂuorescence analysis of Nrf2 protein showed an in-
duction of Nrf2 nuclear translocation especially after exposing the
cells to the highest concentration of rotenone (100 nM) (Fig. 2D, F).
Furthermore, we assessed the expression of Keap1 (Kelch-like ECH-
associated protein 1), a key post-induction repressor of Nrf2 (Bryan
et al., 2013). After 24 h, cells exposed to rotenone, especially to the
highest concentration (100 nM) showed a signiﬁcant decrease of
Keap1 protein levels in the cytoplasm (Fig. 2E), while Keap1 nuclear
fraction did not change signiﬁcantly (not shown).
Nrf2 is a key transcription factor involved in the activation of
several genes that regulate antioxidant defence mechanisms. One
of them is NQO1 (NAD(P)H quinone oxidoreductase 1) that has an
important role in the quinone metabolism (Li et al., 2014; Tufekci
et al., 2011), whereas SRXN1 (sulﬁredoxin 1) catalyzes the
reversal of overoxidation of peroxiredoxins and deglutathionyla-
tion induced by oxidative stress (Tufekci et al., 2011; Zhou et al.,
2015). Immuncytochemical analysis of NQO1 and SRXN1 revealed
a concentration-dependent increase of both protein levels upon
exposure to 10 and 100 nM of rotenone (Fig. 2G). Conversely,
analysis of NQO1, SRXN1 and GSR (glutathione reductase) expres-
sion, known Nrf2-target genes (Gorrini et al., 2013), did not show
signiﬁcant variations among the different rotenone concentrations
(Fig. 2H) when compared to control levels, except for the Nrf2-
target gene HMOX1 (heme oxygenase-1), where tendency to-
wards higher expression was observed in a concentration-
dependent manner (Fig. 2H).
Additionally, to conﬁrm the role of Nrf2 signaling activation
upon induction of oxidative stress, we treated hiPSC-derived neu-
rons with 10 or 100 mM H2O2 (positive control) for 24 hr. These
concentrations of H2O2 were comparable with those found in post-
ischemia state, as reported in previous studies (Bell et al., 2011;
Hyslop et al., 1995). At the highest concentration (100 mM) H2O2
elicited ~ 25% Nrf2 nuclear translocation (Supplementary Fig. 3A,
D), while rotenone at the highest tested concentration (100 nM)
promoted ~ 60% Nrf2 nuclear translocation, as reported above
(Fig. 2D). Additionally, we found that H2O2 increased by ~70% the
level of SRXN1 protein compared to control, whilst NQO1 and
Keap1 protein levels did not change signiﬁcantly (Supplementary
Fig. 3B, C, E and F) in contrast to rotenone (Fig. 2E, G). These re-
sults suggest differences in cell response mechanisms activated
upon exposure to either rotenone or H2O2.
Moreover, qPCR analyses of Nrf2 target genes (i.e., SRXN1, NQO1,
HMOX1 and GSR) showed no signiﬁcant differences between
H2O2etreated vs untreated cells (Supplementary Fig. 3G). The
absence of changes in the expression of Nrf2-target genes uponded in the presence of neural induction (NI) medium or directly differentiated in the
ocytochemical images of IMR90-hiPSC-derived neurons stained for neuroﬁlament 200
(MAP2: red) and synaptophysin (SYN: green) (upper panels), and IMR90-NSC-derived
els). (C) Quantiﬁcation of nestin, MAP2, GFAP, gamma-aminobutyric acid (GABA), ve-
using the Array Scan vTi platform, comparing IMR90-hiPSC-derivatives and derivatives
aster plot of IMR90-NSC-derived neurons obtained from 45 microelectrodes; recording
g rate (MFR, number of spikes/minute) of IMR90-hiPSC-derived neurons, IMR90-NSC-
tenone-induced activation of the Nrf2 pathway in a neuronal model
ernational (2016), http://dx.doi.org/10.1016/j.neuint.2016.09.004
Fig. 2. Effects of rotenone on Nrf2 on nuclear translocation, Keap1 and antioxidant enzyme levels in IMR90-hiPSCs derived neurons. (A) Representative phase bright images
on IMR90-hiPSC-derived neurons treated with 1, 10, 100 nM rotenone for 24 h. (B) Quantiﬁcation of live DAPIþ cells (i.e. non-pyknotic nuclei), after exposure to different con-
centration of rotenone (1, 10, 100 nM) for 24 h and normalized to untreated, control cells (Ctr). (C) Values of MFR (number of spikes/min) of IMR90-hiPSC derived neurons after acute
(24 h) exposure to 1-10-100 nM rotenone, normalized to untreated (Ctr) cells. (D) Quantiﬁcation of Nrf2 protein nuclear translocation (i.e., nuclear: cytoplasmic signals ratios) in
IMR90-hiPSC-derived neurons after 24 h of exposure to rotenone assessed by measurements of ﬂuorescence intensity using HCI analysis. (E) Quantiﬁcation of cytoplasmic Keap1
protein quantiﬁcation assessed by HCI analysis, performed after exposure to rotenone for 24 h. (F) Representative immunocytochemical images of subcellular localization of Nrf2
(arrows indicate nuclear Nrf2 location). (G) Quantitative evaluation of NAD(P)H Quinone Oxidoreductase 1 (NQO1) and Sulﬁredoxin1 (SRXN1) by means of immunocytochemistry
and HCI after concentration-dependent treatment with rotenone for 24 h. (H) qPCR analyses of the Nrf2-target genes NQO1, SRXN1, HMOX1 (Heme Oxygenase-1) and GSR
(Glutathione Reductase) (all values were normalized to b-actin and GAPDH (Glyceraldehyde 3-phosphate dehydrogenase) and then calibrated to untreated (Ctr) cells (dashed line)
(DDCt method)). Values are shown as mean ± S.E.M. of three biological replicates (n ¼ 3) (*p < 0,05, **p < 0.01).
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derived mixed neuronal/glial model is particularly enriched in
neurons (~70e75% of total cells), while astrocytes, which
constitute ~ 25e30% of total cells, have been reported to be the solePlease cite this article in press as: Zagoura, D., et al., Evaluation of the ro
derived from human induced pluripotent stem cells, Neurochemistry Intlocus for Nrf2 activation by H2O2emediated oxidative stress (Bell
et al., 2011).tenone-induced activation of the Nrf2 pathway in a neuronal model
ernational (2016), http://dx.doi.org/10.1016/j.neuint.2016.09.004
Fig. 3. Effects of rotenone on NSCs, neuronal and glial cells. (AeC) Representative immunocytochemical images of nestin (green, A), MAP2 (red, B) and GFAP (red, C, with 40X
magniﬁcation insets) positive cells after exposure to different concentrations of rotenone (1 nM, 10 nM and 100 nM) for 24 h. (D) Quantitative evaluation of the three cell pop-
ulations analyzed by HCI, using the Array Scan vTi platform, after exposure to rotenone. (E) qPCR analyses of Nestin, Pax6 (Paired Box 6), MAP2 and GFAP gene expression (all values
were normalized to b-actin and GAPDH and then calibrated to Ctr cells (dashed line), DDCt method)). All values are shown as mean ± S.E.M. of three biological replicates (n ¼ 3)
(*p < 0,05, **p < 0.01, ***p < 0.001).
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manner after exposure to rotenone
We further analyzed the percentage of nestinþ cells upon
rotenone treatment compared to control group and we could not
ﬁnd signiﬁcant differences among the tested conditions (Fig. 3A,
D), suggesting that number of neural precursor cells did notPlease cite this article in press as: Zagoura, D., et al., Evaluation of the ro
derived from human induced pluripotent stem cells, Neurochemistry Intchanged upon rotenone exposure. We also assessed the effects of
rotenone on advanced neuronal cell differentiation, by analyzing
the level of MAP2 protein via immunoﬂuorescence and HCI, and
we found that MAP2þ cell percentage did not change upon
rotenone treatment (Fig. 3B, D). qPCR analyses of NSC speciﬁc
genes (i.e., Nestin and Pax6) mainly conﬁrmed the immunoﬂu-
orescence and HCI data, showing that both Nestin and Pax6 didtenone-induced activation of the Nrf2 pathway in a neuronal model
ernational (2016), http://dx.doi.org/10.1016/j.neuint.2016.09.004
D. Zagoura et al. / Neurochemistry International xxx (2016) 1e128not signiﬁcantly change upon treatment with rotenone (Fig. 3E).
Interestingly, rotenone induced a concentration-dependent in-
crease of astroglial cells in the IMR90-derived mixed neuronal/
glial cultures, promoting respectively a ~46%, ~57% and ~99%Fig. 4. Effects of rotenone on speciﬁc neuronal subpopulations. (AeC) Representative imm
cells after exposure to different concentrations of rotenone (1 nM, 10 nM and 100 nM) for
analyzed by HCI, using the Array Scan vTi platform, after exposure to rotenone. (E) qPCR ana
Associated Protein 43), GABRA1 (Gamma-Aminobutyric Acid Type A Receptor Alpha1 Subuni
Hydroxylase), NR4A2 (Nuclear Receptor Subfamily 4 Group A Member 2), (all values were
method)). All values are shown as mean ± S.E.M. of three biological replicates (n ¼ 3) (*p
Please cite this article in press as: Zagoura, D., et al., Evaluation of the ro
derived from human induced pluripotent stem cells, Neurochemistry Intincrease in the number of GFAPþ cells compared to control
(Fig. 3C, D), which was also conﬁrmed by qPCR analysis of GFAP
gene expression (Fig. 3E).unocytochemical images of GABA (red, A), VGlut1 (green, B) and TH (green, C) positive
24 h, with 40X magniﬁcation insets. (D) Quantiﬁcation of the three cell populations
lyses of GRIA1 (Glutamate Ionotropic Receptor AMPA Type Subunit 1), GAP43 (Growth
t), GABRA3 (Gamma-Aminobutyric Acid Type A Receptor Alpha3 Subunit), TH (Tyrosine
normalized to b-actin and GAPDH and then calibrated to Ctr cells (dashed line) (DDCt
< 0,05, **p < 0.01).
tenone-induced activation of the Nrf2 pathway in a neuronal model
ernational (2016), http://dx.doi.org/10.1016/j.neuint.2016.09.004
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neurons
It has been previously shown that rotenone selectively elicits a
dopaminergic neuronal cell death, as observed in in vivo (Cannon
et al., 2009; Sherer et al., 2003) and in vitro studies (Testa et al.,
2005). We investigated the effects elicited by a 24 h rotenone
exposure on dopaminergic, GABAergic and glutamatergic neuronal
markers. Immunoﬂuorescence and HCI analysis revealed that the
percentages of GABAergic and glutamatergic neurons did not
signiﬁcantly change upon rotenone treatment (Fig. 4A, B, D).
However, GABAþ neurons appeared less elongated, especially at
100 nM rotenone (Fig. 4A, insets), which could be an indication of
cellular stress. Importantly, THþ cells were signiﬁcantly decreased
by rotenone treatment, especially at the highest tested concentra-
tion (i.e., 10 nM and 100 nM) (Fig. 4C, D).
We also analyzed the gene expression of some speciﬁc
GABAergic (i.e., GABRA1 and GABRA3), glutamatergic (i.e., GRIA1
and GAP43) and dopaminergic (i.e., TH and NR4A2) neuronal-
related genes. These analyses revealed no signiﬁcant variations
for GABRA1, GABRA3 and GRIA1, while the glutamatergic neuron-
related gene GAP43 and, in particular, the dopaminergic gene
NR4A2 (Nurr1) resulted signiﬁcantly downregulated by rotenone
(Fig. 4E). On the contrary, TH gene expression, opposite to TH
protein level (Fig. 4C, D), resulted signiﬁcantly increased, especially
at the highest tested concentration (100 nM, Fig. 4E).
4. Discussion
The current study describes the concentration-dependent ef-
fects of rotenone on the Nrf2 pathway activation in hiPSC-derived
mixed neuronal/glial cultures. HiPSCs- or NSCs-derived neuronal/
glial mixed cultures are considered as promising models for in vitro
neurotoxicity testing, since these neurons can reach advanced stage
of morphological and functional differentiation (Bal-Price et al.,
2010; Hou et al., 2013; Wheeler et al., 2015). Additionally, hiPSCs
can be used for personalized toxicological risk assessment and thus
support the prediction of individual susceptibility to speciﬁc envi-
ronmental compounds (Kumar et al., 2012).
In the present study we have used a previously established
protocol for the differentiation of hiPSCs into mixed neuronal and
glial cell population (Pistollato et al., 2014). The differentiated
cultures were composed of both neurons expressing classical
neuronal marker proteins, such as NF200 andMAP2, synaptophysin
and GFAPþ astrocytes. The presence of astrocytes is important
since they play a fundamental role in neuronal homeostasis
(oxidative stress defence mechanisms, extracellular glutamate
uptake, ions balance, etc.) and function of neuronal networks
(Barker and Ullian, 2008; Bell et al., 2011; Figley and Stroman, 2011;
Santello and Volterra, 2009). Additionally, in line with our previous
report (Pistollato et al., 2014), different neuronal subtypes, such as
GABAergic, glutamatergic and dopaminergic neurons were identi-
ﬁed. The functional maturation of derived neurons was studied by
analysing their electrical activity (MFR) using multi-electrode ar-
rays that is nowadays one of the most reliable tools for neuronal
function evaluation (Odawara et al., 2014). The obtained results
suggest that functional neuronal network was created, however a
lack of synchronized bursting indicates that these neurons did not
reach terminal functional maturation, as it was observed in primary
cultures of rat embryonic cortical neurons.
In parallel, we developed a protocol for the expansion of rosette-
derived NSCs, their cryopreservation and further differentiation
into neuronal cells. Differentiation of neurons from NSCs should
reduce variability and improve reproducibility of the obtained re-
sults. In our studies the proportion of obtained neurons and theirPlease cite this article in press as: Zagoura, D., et al., Evaluation of the ro
derived from human induced pluripotent stem cells, Neurochemistry Intelectrical activity measured by MFR resulted similar, irrespectively
whether the neurons were differentiated directly from hiPSCs or
from NSCs. Considering the presence of ~25e30% of astrocytes in
this mixed neuronal/glial culture, further analyses should be done
to assess whether astrocytes in this mixed hiPSC neuronal/glial
model can contribute to the calcium waves propagation observed
during the generation of neuronal electrical activity. Indeed,
Tamura and colleagues have observed a metabotropic glutamate
receptor 5 (mGluR5)-dependent spontaneous slow Ca2þ oscillation
in both neurons and astrocytes in the striatum of murine brain
slices (Tamura et al., 2014).
Several neurodegenerative diseases are characterized by mito-
chondrial dysfunction and increased oxidative stress (Nicholls and
Budd, 2000; Tufekci et al., 2011), which may result upon exposure
to neurotoxicants. Oxidative stress is one of the early effects
observed in neuronal cultures exposed to different classes of
chemicals, including inhibitors of mitochondrial respiration chain
such as rotenone (Peng et al., 2013). In an effort to restore ho-
meostasis, neuronal cells respond to these chemical entities by
activating signaling pathways, such as the Nrf2/ARE, which is
known to play a cytoprotective, antioxidant and anti-inﬂammatory
role (Lee et al., 2003; Shih et al., 2005; Tufekci et al., 2011). Under
physiological conditions the protein levels of Nrf2 are kept low in
the cytoplasm due to the rapid proteasome-mediated turnover
facilitated by the Keap1 protein, which acts as a Nrf2-speciﬁc ligase
adaptor protein (Gorrini et al., 2013; Hartikainen et al., 2012;
Harvey et al., 2009; Kansanen et al., 2013). In response to various
extracellular signals triggering oxidative stress the inhibitory ef-
fects of Keap1 on Nrf2 is interrupted, Nrf2 dissociates from Keap1
resulting in translocation and accumulation in the nucleus (Kovac
et al., 2015; Tufekci et al., 2011). Therefore in the present study
we have evaluated both Nrf2 and Keap1 expression upon an
exposure to rotenone (positive control) that is known to induce ROS
production upon inhibition of complex I of mitochondrial respira-
tory chain (Satoh et al., 2009).
Here, we show that a concentration-dependent exposure to
rotenone for 24 h caused an activation of Nrf2 pathway causing
Nrf2 nuclear translocation, as shown by immunocytochemical
analysis and HCI of Nrf2 protein levels. In parallel, we found that
rotenone elicited a signiﬁcant decrease of cytoplasmic Keap1
protein.
Recent studies suggest that Keap1 has a dual role in maintaining
cellular homeostasis after exposure to chemicals, by providing
dependent and independent regulation of the Nrf2 pathway (Bryan
et al., 2013). Previous observations have revealed that upon
oxidative stress, Keap1 exhibits a conformational change that re-
sults in the release of Nrf2 and its trafﬁcking and accumulation into
the nucleus, in order to bind to gene promoter regions containing
ARE (Harder et al., 2015; Lee et al., 2003; Ramsey et al., 2007).
Notwithstanding, recent publications also support the idea that
Keap1 could be involved in a post-induction repressor of Nrf2
signaling, due to its ability to independently enter into the nucleus,
dissociate Nrf2 from ARE, and transfer Nrf2 back to the cytoplasm
(Bryan et al., 2013; Satoh et al., 2009; Sun et al., 2007). As both
Keap1-dependent and independent mechanisms of regulation of
the Nrf2 pathway have been described (Bryan et al., 2013) further
studies are needed to clarify the signiﬁcance of our data, showing a
reduction of cytoplasmic Keap1 levels upon rotenone treatment
(Fig. 2E).
Nrf2 plays a pivotal role in the transcription of several ARE-
dependent cytoprotective genes including NQO1 and SRXN1 (Itoh
et al., 1997; Li et al., 2014) that were evaluated in this study after
exposure to rotenone at different concentrations (1, 10 and
100 nM). While qPCR analysis did not reveal signiﬁcant variations
of gene expression, apart from a modest upregulation of HMOX1tenone-induced activation of the Nrf2 pathway in a neuronal model
ernational (2016), http://dx.doi.org/10.1016/j.neuint.2016.09.004
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increased in a concentration-dependent manner upon treatment
with rotenone, which conﬁrms activation of the Nrf2 pathway (Li
et al., 2014). Presumably, rotenone-induced inhibition of complex
I triggered ROS production, followed by Nrf2 pathway activation
(Barrientos and Moraes, 1999). Increased ROS production causes
oxidative damage to DNA, lipids and proteins, and up regulation of
NQO1 and SRXN1 protects cells against these effects. NQO1 cata-
lyzes the reduction of highly reactive quinones that can cause redox
cycling and oxidative stress, while SRXN1 reduces cysteine-sulﬁnic
acid formed under exposure to oxidants in the peroxiredoxins
PRDX1, PRDX2, PRDX3 and PRDX49 (Ma, 2013). Additionally, Nrf2
directly affects homeostasis of ROS by catabolism of superoxide and
peroxides, regeneration of oxidized cofactors and proteins, syn-
thesis of reducing factors (i.e., reduced glutathione by glutamate-
cysteine ligase catalytic subunit, etc.) (Ma, 2013). Although the list
of Nrf2 target genes varies depending on cell type, Nrf2 is critical to
the cellular defense mechanisms in many tissues, including the
brain (Lee et al., 2003; Shih et al., 2005).
In the same study, we also detected a concentration-dependent
increase of GFAP gene expression and protein level (by immuno-
cytochemistry), after exposure to rotenone, which could indicate
astrocyte activation (Bal-Price et al., 2010; Cabezas et al., 2012;
Swarnkar et al., 2012). It is well known that astrocytes respond to
different neurological insults, such as oxidative stress, by reactive
astrogliosis, which involves the increase of astrocytes, molecular
and conformational changes of the cells, and GFAP up-regulation,
which is controlled by different cytokines and neurohormones
(Radad et al., 2008; Swarnkar et al., 2012). Astrocyte-speciﬁc Nrf2
target genes play an important role in antioxidant and anti-
inﬂammatory effects in brain. Recently it was reported that Nrf2
regulates the synthesis and release of reduced glutathione (GSH) by
astrocytes (Steele et al., 2013). Another study suggests that neuro-
protective effect of Nrf2 involves genetic remodeling (i.e., ARE-
driven gene expression) of both astrocytes and neurons (Lee
et al., 2003). Indeed, Nrf2-knockout mice were signiﬁcantly more
sensitive to mitochondrial complex I and II inhibitors and trans-
planted Nrf2-overexpressing astrocytes into the mouse striatum,
prior to lesioning with malonate, led to dramatic protection against
neurotoxicity, suggesting that astrocytes are central to Nrf2-ARE
mediated neuroprotection (Johnson et al., 2008).
Opposite to Pei's study (Pei et al., 2016) we did not observe
signiﬁcant variations in the percentages of both nestinþ andMAP2þ
cells. It should also be considered that the concentrations tested in
our study are about 103 times lower than the ones tested in Pei's
experiments (i.e., 1 and 10 mM respectively) (Pei et al., 2016), which
could contribute to the differences in rotenone effects observed in
our study.
Decreased number of THþ cells induced by rotenone (Fig. 4C, D),
is in line with previous studies showing a selective dopaminergic
neuronal cell death caused by rotenone in vitro (Testa et al., 2005)
and in vivo (Cannon et al., 2009; Sherer et al., 2003). Dopaminergic
neurons are the most vulnerable population of neurons to various
stressors, including oxidative stress (Fujita et al., 2014). Interest-
ingly, rotenone was also reported to upregulate TH mRNA, as
described in PC12 cells cultured at 20% oxygen (Hohler et al., 1999).
The observed increase of TH gene expression particularly at the
highest tested rotenone concentration (100 nM, Fig. 4E) could be
possibly associated with compensatory mechanisms induced in the
surviving cells to recover the reduction of TH protein elicited by the
acute exposure to rotenone.
Moreover, acute treatment with rotenone did not elicit signiﬁ-
cant changes in electrical activity of hiPSC-derived cultures (Fig. 2C
and Supplementary Fig. 2) when compared to the control cultures.
On the contrary, Gao and co-workers have shown that rotenone at 1Please cite this article in press as: Zagoura, D., et al., Evaluation of the ro
derived from human induced pluripotent stem cells, Neurochemistry Intand 3 mM can decrease the delayed rectiﬁer Kþ current (IDR)
amplitude, whilst not having effect on A-type current (IA) peak
amplitude (Gao et al., 2008). However, possible extrapolations of
these data might be challenging, considering that Gao's study was
conducted on cultured ventral mesencephalic rodent neurons
(rather than hiPSC-derived neurons), using whole-cell patch clamp
(rather than multi-electrode array).
In conclusion, the obtained data indicate that hiPSC-derived
mixed neuronal/glial culture could be a valuable tool for studying
the neurotoxic effects of chemicals that induce oxidative stress,
particularly if Nrf2 pathway becomes activated. However, it will be
important to assess Nrf2 activation across different classes of
chemicals, in order to identify which speciﬁc genes/proteins are up-
or down-regulated in order to be used as potential biomarkers of
Nrf2 signaling pathway activation. Oxidative stress is an important
and common key event in various Adverse Outcome Pathways
(AOPs) relevant to developmental and adult neurotoxicity (Bal-
Price et al., 2015b). The deﬁned AOP key events, including Nrf2
pathway activation, could serve as a base for assay development
needed to build integrated testing strategies (Bal-Price et al.,
2015a), such as AOP-informed IATA (Integrated Approaches to
Testing and Assessment) for neurotoxicity testing (Tollefsen et al.,
2014), providing mechanistic knowledge to facilitate regulatory
decision making process.
5. Conclusions
The obtained data suggest that mixed, neuronal/glial culture
derived from hiPSCs could serve as a promising model for in vitro
neurotoxicity testing of chemicals that induce oxidative stress and
trigger Nrf2 pathway activation. Moreover, NQO1 and SRXN1,
speciﬁc Nrf2-target genes, could be possibly recognized as bio-
markers of chemically induced oxidative stress.
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